+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins



Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins



Clinical and Experimental Immunology 41(2): 189-195



The autologous phase of passive Heymann's nephritis (PHN) induced in rats by a single injection of rabbit IgG anti-FxlA has been investigated. Tolerance to normal rabbit IgG prior to induction of PHN abolished or strongly diminished the glomerular deposition of the host's IgG during the early autologous phase and prevented the development of proteinuria. Neonatal thymectomy significantly decreased the anti-rabbit IgG response but did not prevent the development and the progression of glomerulopathy. Passive transfer of rat or sheep anti-rabbit IgG hyperimmune serum during the heterologous phase resulted in an earlier accumulation of the injected IgG along the glomerular capillary walls (GCW). These results demonstrate the importance of the host's humoral immune response to the injected rabbit IgG anti-FxlA antibody in the progression and in the maintenance of glomerular immune lesions.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043887669

Download citation: RISBibTeXText

PMID: 7002394


Related references

Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis. Japanese Journal of Pharmacology 49(1): 101-110, 1989

The contribution of antibody-mediated cytotoxicity and immune-complex formation to tubulointerstitial disease in passive Heymann nephritis. Clinical Immunology and Immunopathology 62(1 Pt 1): 42-55, 1992

Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis. Journal of Pathology 210(3): 282-287, 2006

Monocyte involvement in experimental immune complex nephritis passive heymann nephritis. Experimental Cell Biology 57(2): 98, 1989

The long-term evolution of immune deposits in passive Heymann nephritis. Brazilian Journal of Medical and Biological Research 25(2): 149-159, 1992

Initial events in the formation of immune deposits id in passive heymann nephritis phn. Kidney International: 170, 1987

Studies of the role of antibodies to glycolipids in the pathogenesis of passive Heymann nephritis. Journal of the American Society of Nephrology 5(3): 768, 1994

Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. American Journal of Pathology 144(4): 807-819, 1994

The cell biology of Heymann nephritis: a model of human membranous glomerulonephritis. American Journal of Kidney Diseases 10(1): 74-76, 1987

Quantification of immune deposits in passive heymann nephritis by double labeling immunoelectron microscopy. Japanese Journal of Clinical Electron Microscopy 24(5-6): 898-899, 1991

Comparative study of in situ immune deposit formation in active and passive heymann nephritis. Kidney International 23(3): 498-505, 1983

Comparative study of subepithelial immune deposit formation in active and passive heymann nephritis. Kidney International 19(1): 186, 1981

Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis. American Journal of Pathology 149(4): 1313-1320, 1996

Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. Journal of Clinical Investigation 100(9): 2303-2309, 1997

Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. Journal of Experimental Medicine 164(6): 1973-1987, 1986